These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29354557)

  • 1. Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis.
    Bridgeman MB
    Integr Pharm Res Pract; 2017; 6():109-119. PubMed ID: 29354557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Allergic Rhinitis: A Review for the Community Pharmacist.
    May JR; Dolen WK
    Clin Ther; 2017 Dec; 39(12):2410-2419. PubMed ID: 29079387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of allergic rhinitis in the era of effective over-the-counter treatments.
    Carr WW; Yawn BP
    Postgrad Med; 2017 Aug; 129(6):572-580. PubMed ID: 28532204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases.
    Smith P; Price D; Harvey R; Carney AS; Kritikos V; Bosnic-Anticevich SZ; Christian L; Skinner D; Carter V; Durieux AMS
    J Asthma Allergy; 2017; 10():153-161. PubMed ID: 28533689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal allergies in the Middle Eastern population: results from the "Allergies in Middle East Survey".
    Abdulrahman H; Hadi U; Tarraf H; Gharagozlou M; Kamel M; Soliman A; Hamad WA; Hanna KM; Mostafa BE; Omrani M; Abdelmotal A; Moukarzel N
    Am J Rhinol Allergy; 2012; 26 Suppl 1():S3-23. PubMed ID: 23232281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.
    Wingertzahn MA; Derebery MJ; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S18-24. PubMed ID: 18307840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index.
    Daley-Yates PT; Larenas-Linnemann D; Bhargave C; Verma M
    J Asthma Allergy; 2021; 14():1093-1104. PubMed ID: 34526783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal corticosteroids in the treatment of allergic rhinitis.
    Ratner PH; Stoloff S; Meltzer EO; Hadley JA
    Allergy Asthma Proc; 2007; 28 Suppl 1():S25-32. PubMed ID: 18307841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsaicin for non-allergic rhinitis.
    Gevorgyan A; Segboer C; Gorissen R; van Drunen CM; Fokkens W
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010591. PubMed ID: 26171907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey.
    Shedden A
    Treat Respir Med; 2005; 4(6):439-46. PubMed ID: 16336028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal allergies in the Middle Eastern population: Results from the "Allergies in Middle East Survey".
    Abdulrahman H; Hadi U; Tarraf H; Gharagozlou M; Kamel M; Soliman A; Hamad WA; Hanna KM; Mostafa BE; Omrani M; Abdelmotal A; Moukarzel N
    Am J Rhinol Allergy; 2012 Nov; 26(6):3-23. PubMed ID: 29025459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of treatments for allergic rhinitis in children.
    Baena-Cagnani CE
    Drug Saf; 2004; 27(12):883-98. PubMed ID: 15366976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
    May JR; Dolen WK
    Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting congestion in allergic rhinitis: the importance of intranasal corticosteroids.
    Marple BF
    Allergy Asthma Proc; 2008; 29(3):232-40. PubMed ID: 18534080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE; Meltzer EO
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids.
    Blaiss MS
    Curr Med Res Opin; 2008 Mar; 24(3):821-36. PubMed ID: 18257976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study.
    Meltzer EO;
    Clin Ther; 2002 Jun; 24(6):942-52. PubMed ID: 12117084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study.
    Carney AS; Price DB; Smith PK; Harvey R; Kritikos V; Bosnic-Anticevich SZ; Christian L; Skinner DA; Carter V; Durieux AM
    Pragmat Obs Res; 2017; 8():157-165. PubMed ID: 28919832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.